Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Halozyme Gets Key Validation of Enzyme Technology in HyQvia Approval

September 17, 2014 – 9:42 am | Edit Post
Halozyme Gets Key Validation of Enzyme Technology in HyQvia Approval

Shakespeare wrote, “The course of true love never did run smooth,” and San Diego’s Halozyme Therapeutics (NASDAQ: HALO) could say pretty much the same thing about the FDA approval process. When the…

[[Click headline to continue reading.]]

Capturing Ancient Maya Sites from Both a Rat’s and a ‘Bat’s Eye View’

September 16, 2014 – 12:39 pm | Edit Post
Capturing Ancient Maya Sites from Both a Rat’s and a ‘Bat’s Eye View’

A trip to the Guatemalan jungle usually nets a few souvenirs: Photographs of Maya ruins, bragging rights about encounters with venomous snakes, perhaps a bug bite or two.

Capturing Ancient Maya Sites from Both a Rat’s and a ‘Bat’s Eye View’

September 16, 2014 – 12:39 pm | Edit Post
Capturing Ancient Maya Sites from Both a Rat’s and a ‘Bat’s Eye View’

A trip to the Guatemalan jungle usually nets a few souvenirs: Photographs of Maya ruins, bragging rights about encounters with venomous snakes, perhaps a bug bite or two.

Novel Drug Targeting Leukemia Cells Enters Clinical Trial

September 16, 2014 – 9:26 am | Edit Post

Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common …

Novel Drug Targeting Leukemia Cells Enters Clinical Trial

September 16, 2014 – 9:26 am | Edit Post

Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common …

From the American Association for Cancer Research—what you should know about cancer in 2014

September 16, 2014 – 8:12 am | Edit Post

AACR 2014 Progress Report

From the American Association for Cancer Research—what you should know about cancer in 2014

September 16, 2014 – 8:12 am | Edit Post

AACR 2014 Progress Report

Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors

September 16, 2014 – 4:30 am | Edit Post

Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors

Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors

September 16, 2014 – 4:30 am | Edit Post

Marina Biotech Announces the Election of Donald A. Williams to Its Board of Directors

Cancer and the Immune System: A Double-Edged Sword

September 15, 2014 – 12:00 pm | Edit Post

During cancer development, tumor cells decorate their surfaces with sugar compounds called glycans that are different from those found on normal, healthy cells. Researchers at the University of California, San Diego School of Medicine report that sialic acids at the tips of these cancer cell glycans are capable of engaging with immune system cells and changing the latter’s response to the tumor – for good and bad.